Why do women discontinue contraception and what are the post-discontinuation outcomes? Evidence from the Arusha Region, Tanzania.


Journal

Sexual and reproductive health matters
ISSN: 2641-0397
Titre abrégé: Sex Reprod Health Matters
Pays: England
ID NLM: 101743493

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 18 3 2020
pubmed: 18 3 2020
medline: 9 4 2020
Statut: ppublish

Résumé

In Africa, high discontinuation of contraceptive use is thwarting goals for healthy birth spacing or limiting childbearing. This paper investigates how well the contraception program is addressing the needs of women and couples in the Arusha region, Tanzania by studying contraceptive use continuation. We measured the overall and method-specific discontinuation rate, reasons for discontinuation, post-discontinuation reproductive behaviours/outcomes, and examined the determinants of contraceptive discontinuation. We used data from a household survey conducted in Arusha from January to May 2018. Information on contraceptive use during the 31 months preceding the survey was recorded in a monthly calendar. Using the single- and multiple-decrement life-table approach, we calculated the overall and cause-specific discontinuation of contraceptive methods. Logistic regression was used to evaluate the determinants of discontinuation. The 12-month overall discontinuation of contraceptive use was 44.6%. Discontinuation was lowest for implants (12.3%) and highest for male condoms (60.1%), the most common reason being side effects (11.7%). 59.8% of women who discontinued did not switch to another method within 3 months following discontinuation and 20.9% experienced pregnancy. Longer distance to a health facility is associated with higher discontinuation of hormonal methods such as injectables, but lower discontinuation of non-hormonal methods such as condoms. Discontinuation due to side effects is not explained by most of the women's background characteristics other than the method they used. Discontinuation of contraception is high among Arusha women. Effective contraception programs, especially improved counselling, need to address the reasons for the discontinuation of contraceptive use.

Identifiants

pubmed: 32178594
doi: 10.1080/26410397.2020.1723321
pmc: PMC7888019
doi:

Substances chimiques

Contraceptive Agents, Female 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1723321

Références

Lancet Glob Health. 2018 Apr;6(4):e380-e389
pubmed: 29519649
Reprod Health. 2017 Apr 27;14(1):56
pubmed: 28449723
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41
pubmed: 24135045
PLoS One. 2017 Nov 13;12(11):e0187311
pubmed: 29131860
Bull World Health Organ. 2011 Feb 1;89(2):137-43
pubmed: 21346925
Reprod Health. 2017 Oct 17;14(1):130
pubmed: 29041936
Popul Dev Rev. 2017 May;43(Suppl Suppl 1):166-191
pubmed: 29081552
Lancet Glob Health. 2015 Jul;3(7):e366-77
pubmed: 25999096
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):577-82
pubmed: 9757954
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
BMC Womens Health. 2015 Nov 03;15:97
pubmed: 26530029

Auteurs

Ryoko Sato (R)

Research Associate, Harvard TH Chan School of Public Health, Boston, MA, USA. Correspondence: rsato@hsph.harvard.edu, ryokos1226@gmail.com.

Bilikisu Elewonibi (B)

Research Associate, Harvard TH Chan School of Public Health, Boston, MA, USA.

Sia Msuya (S)

Associate Professor, Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Rachel Manongi (R)

Associate Professor, Kilimanjaro Christian Medical University College, Moshi, Tanzania.

David Canning (D)

Professor, Harvard TH Chan School of Public Health, Boston, MA, USA.

Iqbal Shah (I)

Principal Research Scientist, Harvard TH Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH